Shenzhen Neptunus Bioengineering Co., Ltd. (SHE:000078)
China · Delayed Price · Currency is CNY 1.530
-0.020 (-1.29%)
Sep 10, 2026, 2:45 PM CST
SHE:000078 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
| 4,078 | 9,104 | 6,709 | 8,638 | 9,133 | 9,710 | |
Market Cap Growth | -40.61% | 35.69% | -22.32% | -5.42% | -5.95% | -11.97% |
Enterprise Value | 12,682 | 18,465 | 15,571 | 18,975 | 19,108 | 20,151 |
Last Close Price | 1.55 | 3.46 | 2.55 | 3.14 | 3.32 | 3.53 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | - | - | - | - | - | 104.08 |
Forward PE | - | 18.08 | 18.08 | 18.08 | 18.08 | 18.08 |
PS Ratio | 0.17 | 0.34 | 0.22 | 0.24 | 0.24 | 0.24 |
PB Ratio | 2.20 | 4.18 | 2.36 | 2.05 | 1.49 | 1.33 |
P/TBV Ratio | 8.57 | 13.77 | 6.40 | 4.91 | 3.60 | 3.17 |
P/FCF Ratio | 429.64 | - | - | - | - | 13.18 |
P/OCF Ratio | 49.78 | 87.21 | 169.69 | - | - | 11.21 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
EV/Sales Ratio | 0.54 | 0.69 | 0.51 | 0.52 | 0.51 | 0.49 |
EV/EBITDA Ratio | 45.87 | 46.14 | 45.18 | 23.24 | 20.35 | 12.34 |
EV/EBIT Ratio | 139.82 | 72.49 | 88.03 | 30.67 | 24.98 | 13.81 |
EV/FCF Ratio | 1336.07 | - | - | - | - | 27.35 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Debt / Equity Ratio | 5.50 | 5.38 | 3.72 | 2.70 | 1.95 | 1.72 |
Debt / EBITDA Ratio | 36.84 | 24.89 | 25.05 | 12.63 | 11.45 | 7.28 |
Debt / FCF Ratio | 1073.04 | - | - | - | - | 17.07 |
Net Debt / Equity Ratio | 4.19 | 3.95 | 2.45 | 1.78 | 1.35 | 1.15 |
Net Debt / EBITDA Ratio | 33.24 | 21.50 | 20.24 | 9.19 | 8.75 | 5.16 |
Net Debt / FCF Ratio | 818.95 | -379.07 | -154.79 | -14.59 | -51.81 | 11.42 |
Asset Turnover | 0.92 | 0.97 | 0.99 | 1.06 | 1.02 | 1.06 |
Inventory Turnover | 6.82 | 7.23 | 7.67 | 8.36 | 8.53 | 9.52 |
Quick Ratio | 0.83 | 0.85 | 0.85 | 0.88 | 0.87 | 0.90 |
Current Ratio | 0.98 | 1.00 | 1.01 | 1.04 | 1.06 | 1.06 |
Return on Equity (ROE) | -34.86% | -22.01% | -33.06% | -33.28% | -14.77% | 3.48% |
Return on Assets (ROA) | 0.22% | 0.58% | 0.36% | 1.13% | 1.29% | 2.36% |
Return on Invested Capital (ROIC) | 0.92% | 2.47% | 1.64% | 4.75% | 5.09% | 4.09% |
Return on Capital Employed (ROCE) | 4.10% | 9.70% | 5.50% | 13.50% | 11.70% | 18.60% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Earnings Yield | -19.58% | -6.19% | -17.79% | -19.56% | -11.24% | 0.96% |
FCF Yield | 0.23% | -0.25% | -0.67% | -5.95% | -1.74% | 7.59% |
Payout Ratio | - | - | - | - | - | 605.79% |
Buyback Yield / Dilution | 0.45% | -0.01% | 0.00% | -0.05% | -0.07% | -0.19% |
Total Shareholder Return | 0.45% | -0.01% | 0.00% | -0.05% | -0.07% | -0.19% |